Skip to main content

Article-series: AYURVEDIC MANAGEMENT OF PITTODARA ASSOCIATED WITH JIRNA ATISARA (ULCERATIVE COLITIS): A SINGLE CASE STUDY

 AYURVEDIC MANAGEMENT OF PITTODARA ASSOCIATED WITH JIRNA  ATISARA  (ULCERATIVE COLITIS): A SINGLE CASE STUDY

 

Vaishali Lalwani¹, Shubham Tripathi², Soni Surendra³, Soni Anamika⁴

  1. 2nd Year MD Scholar, An Upgraded PG Department of Kayachikitsa, Govt. Akhandanand Ayurved College, Ahmedabad, Gujarat
  2. 2nd  Year MD Scholar, An Upgraded PG Department of Kayachikitsa, Govt. Akhandanand Ayurved College, Ahmedabad, Gujarat
  3. Professor and Head, An Upgraded PG Department of Kayachikitsa, Govt. Akhandanand Ayurved College, Ahmedabad, Gujarat
  4. Associate Professor, An Upgraded PG Department of Kayachikitsa, Govt. Akhandanand Ayurved College, Ahmedabad, Gujarat

 

ABSTRACT


Ulcerative Colitis (UC) is a chronic inflammatory bowel disease characterized by continuous mucosal inflammation, ulceration and rectal bleeding. From an Ayurvedic perspective, the present case was correlated with Pittodara, a form of Udara Roga associated with aggravated Pitta, Agni Dushti, Ama formation, Srotodushti and Dhatu Kshaya. A 42-year-old female presented with 20–25 episodes/day of mucoid watery stools with occasional bleeding, abdominal heaviness, distension, weakness and progressive weight loss. Colonoscopy showed ulcerative pancolitis with continuous inflammation throughout the colon, and biopsy confirmed chronic moderately active ulcerative colitis. The patient received Shamana Chikitsa with Kutaj Ghanavati, Sanshamani Vati, Sudarshan Ghanavati and Dadimadi Ghrita, along with Tikta Skandha Kshira Basti for 40 days. The treatment was planned on principles of Deepana, Ama Pachana, Stambhana, Srotoshodhana, Vrana Ropana and Brimhana. Bowel frequency decreased to 2–3 episodes/day, with complete resolution of mucous discharge and rectal bleeding, improvement in appetite and strength, and weight gain. Follow-up colonoscopy demonstrated marked mucosal healing and near-complete endoscopic remission, with Mayo score improving from 3 to 1 and UCEIS from 6–8 to 2. No treatment-related adverse events were reported. This single case suggests that Samprapti Vighatana-based Ayurvedic approach may have potential as a complementary management strategy in chronic active ulcerative pancolitis; however, larger controlled studies are required.

KEYWORDS: Pittodara; Ulcerative Colitis; Kshira Basti;Samprapti Vighatana; Ayurveda.


INTRODUCTION


Ulcerative Colitis (UC) is a chronic inflammatory bowel disease characterized by continuous mucosal inflammation that invariably begins in the rectum and extends proximally in a continuous pattern, potentially involving the entire colon (ulcerative pancolitis). Histopathologically, the inflammation is confined to the mucosa and lamina propria and is characterized by cryptitis, crypt abscess formation, goblet cell depletion, and superficial ulceration. Clinically, patients commonly present with recurrent episodes of bloody diarrhoea, rectal bleeding, mucopurulent stools, abdominal pain, and urgency, with disease severity varying according to the extent of colonic involvement. Chronic inflammation may subsequently result in pseudopolyps, colonic shortening, fibrosis, and dysplastic changes, emphasizing the importance of timely and effective therapeutic intervention. [1]

From an Ayurvedic perspective, chronic gastrointestinal disorders such as Atisara, Pravahika, Grahani, and Arsha, when neglected or inadequately managed, ultimately progress towards the spectrum of Udara Roga, particularly in the presence of Dhatu Kshaya and persistent Agnimandya. The present case demonstrates features consistent with Pittodara, a subtype of Udara Roga, in which aggravated Pitta Dosha, associated with Vata and Kapha, produces Srotorodha and significantly impairs Jatharagni at the level of the Aamashaya and Mahasrotas. [3]

The underlying pathology may be understood as a chronic persistence of Amla Avastha Paka, resulting in sustained derangement of digestive and metabolic processes. Progressive Agnidushti leads to Ama formation, Pitta Prakopa, Rakta Dushti, and mucosal injury, producing ulceration, bleeding, and inflammatory changes within the colon. With increasing chronicity, the disease extends beyond the Koshtha (gastrointestinal tract) to involve the Shakha (peripheral tissues), Marma-Asthi-Sandhi (vital organs and structural tissues), and Satva (mental well-being), transforming a localized gastrointestinal disorder into a systemic disease process. [3]

Considering these pathological principles, Ayurvedic management aims not only at symptomatic relief but also at restoring Agni, eliminating Ama, correcting Dosha imbalance, promoting Srotoshodhana, facilitating Vrana Ropana (mucosal healing), and replenishing depleted tissues (Dhatu Poshana), thereby addressing the disease at its root and reducing the likelihood of recurrence. [3]

 

CASE PRESENTATION


A 42-year-old female presented with a history of chronic gastrointestinal complaints with progressive worsening of symptoms. The chief complaints included:

  • Picchila Drava Mala Pravritti (frequent passage of mucoid watery loose stools; 20–25 episodes/day) since 10-15 years
  • Udara Gauravata & adhman(persistent abdominal heaviness) since 4-5 years
  • Daurbalyata (generalized weakness and easy fatigability) since 4-5 years
  • Sharira Bhara Hani (progressive weight loss) since 4-5 years
  • Jaliya Nasa Srava (watery nasal discharge) since 1 month

The patient had significant impairment in daily activities due to increased bowel frequency and associated constitutional symptoms.

Investigations

Colonoscopy -29/08/25

  • Diffuse ulcerative pancolitis with continuous mucosal inflammation involving the entire colon, extending from the rectum to the proximal colon.

Histopathological Examination

  • Colonic biopsy revealed features consistent with chronic moderately active ulcerative colitis, confirming the diagnosis.

Personal History

  • Ahara Shakti (Appetite): Reduced
  • Mala Pravritti (Bowel Habits): Frequent mucoid watery loose stools (20–25 episodes/day)
  • Mutra Pravritti (Micturition): Normal
  • Nidra (Sleep): Disturbed
  • Vyasana (Addiction): None
  • Ahara Vihara: Irregular dietary habits with poor nutritional intake secondary to chronic illness.

 

SAMPRAPTI (PATHOGENESIS)


Nidana Sevana
(Pitta-provoking diet, Vidahi Ahara, incompatible food, and faulty lifestyle)
⬇
Pitta Prakopa with Vata–Kapha Anubandha
(Aggravation of Pitta associated with Vata and Kapha)
⬇
Srotorodha & Unmarga Gamana
(Obstruction of microchannels and derangement of the normal physiological pathways)
⬇
Jatharagni Dushti in Aamashaya
(Impairment of digestive fire leading to Agnimandya)
⬇
Disturbance of Mahasrotas Avastha Paka
(Persistent derangement of digestion with chronic Amla Avastha Paka and Ama formation)
⬇
Formation of Sama Pitta & Sama Rasa &Rakta Dhatu
(Generation of inflammatory toxic metabolites with vitiation of Rasa &Rakta Dhatu)
⬇
Vyapti to Shakha, Marma, Asthi-Sandhi & Satva
(Systemic dissemination of pathology beyond the gastrointestinal tract)
⬇
Dhatu Poshana Avarodha & Progressive Dhatu Kshaya
(Impaired tissue nourishment resulting in progressive tissue depletion)
⬇
Karshya, Daurbalya & Ojakshaya
(Weight loss, generalized weakness, and reduced vitality)
⬇
Sthanika Dushya-Dushti in Purishavaha Srotas
(Localization of pathology in the colonic mucosa)
⬇
Shotha • Daha • Rakta Srava • Picchila Mala Pravritti • Adhmana
(Mucosal inflammation, burning sensation, rectal bleeding, mucoid diarrhea, and abdominal distension)
⬇

PITTODARA


According to Ayurveda, the pathogenesis of Pittodara is a dynamic and progressive process that originates from the persistent indulgence in Pitta-provoking Nidanas. Excessive consumption of Katu (pungent), Amla (sour), Lavana (salty), Ushna (hot), Tikshna (penetrating), and Vidahi (irritant) food substances, along with incompatible dietary practices (Viruddha Ahara), Adhyashana (consuming food before the previous meal is digested), irregular eating habits, prolonged exposure to heat or sunlight, psychological stress, and pre-existing gastrointestinal disorders collectively initiate the pathological process. Individuals possessing Pitta Prakriti, Rakta Sara, younger age, or a predisposition to gastrointestinal disorders are particularly susceptible to the development of this condition. [3]

Acharya Charaka has explained the initial stage of this pathological cascade through the fundamental principle of "Raso Nipate Dravyanam," wherein ingested substances exert their direct influence upon the gastrointestinal mucosa immediately after contact. Under physiological conditions, the protective action of Kledaka Kapha and the mucosal barrier safeguards the gastrointestinal lining from chemical injury. However, persistent exposure to Pitta-provoking substances overwhelms these protective mechanisms, resulting in progressive mucosal irritation, congestion, inflammation, epithelial injury, and ulceration. This stage bears a remarkable resemblance to the early pathological events of ulcerative colitis, where disruption of the epithelial barrier initiates continuous mucosal inflammation. [4]

As the disease progresses, aggravated Pitta Dosha associates with Vata (Anila) and Kapha, resulting in a complex Tridoshaja pathological state with predominant Pitta. The synergistic vitiation of these Doshas leads to Srotorodha (obstruction of physiological channels) and Unmarga Gamana (deviation from normal physiological pathways). Consequently, the vitiated Doshas localize in the Aamashaya, where they impair Jatharagni, that may manifest as Tikshnagni, Vishamagni, and eventually Mandagni. Failure of Agni disrupts the normal sequential process of Avastha Paka, causing persistent retention and predominance of Amla Avastha Paka within the Mahasrotas. [3]

The chronic derangement of Avastha Paka initiates the formation of Ama, Sama Pitta, and Sama Rasa& Rakta Dhatu. This toxic metabolic complex establishes a sustained inflammatory milieu within the gastrointestinal tract. From a contemporary perspective, this stage may be correlated with persistent oxidative stress, intestinal dysbiosis, disruption of epithelial tight junctions, activation of inflammatory cytokines, excessive immune responses, and continuous mucosal injury. Thus, the pathological process gradually transforms from a functional disturbance of digestion into an established chronic inflammatory disease. [3]

Persistent Agnimandya together with repeated episodes of diarrhoea severely compromises Dhatu Poshana. The continuous loss of nutrients, impaired digestion, and defective tissue metabolism progressively arrest the normal sequence of nourishment from Rasa to subsequent Dhatus. Consequently, Rasa, Rakta, Mamsa, and Meda Dhatus undergo progressive Kshaya, producing clinical manifestations such as Karshya (weight loss), Daurbalya (generalized weakness), anorexia, fatigue, and reduced vitality. Simultaneously, depletion of Kapha weakens the protective integrity of the intestinal mucosa, whereas accumulated Vata further aggravates intestinal motility and structural instability, perpetuating the disease process. [3]

Because of the chronicity of the disease, the pathological process is no longer confined to the Koshtha. The circulating Sama Pitta and Sama Rasa Dhatu disseminate through the Mahasrotas into the Shakha, Marma, Asthi-Sandhi, and Satva. This transition represents the evolution of a localized gastrointestinal disorder into a systemic pathological process involving peripheral tissues, vital structures, and the psychoneuro-immunological axis. The involvement of Satva explains the close relationship between emotional stress and disease exacerbation, which is well recognized in patients with ulcerative colitis. [3]

Ultimately, the pathological process undergoes Sthana Samshraya within the Purishavaha Srotas, where severe Sthanika Dhatu Dushti develops. The vitiated Pitta predominantly affects Rakta Dhatu, producing vascular congestion, increased capillary fragility, and recurrent rectal bleeding (Rakta Srava). Simultaneously, Mamsa Dhatu involvement results in mucosal erosion and ulcer formation (Vrana), while Kapha Dushti contributes to excessive mucous secretion (Picchila Srava). Vata aggravation further manifests as abdominal pain, urgency, tenesmus, and altered bowel motility. The combined effects of Shotha (mucosal inflammation), Daha (burning sensation), Rakta Srava, Picchila Drava Mala Pravritti, and Adhmana closely resemble the pathological and clinical features of chronic active ulcerative pancolitis, including diffuse mucosal inflammation, cryptitis, crypt abscess formation, goblet cell depletion, and continuous ulceration of the colonic mucosa. [3]

From an Ayurvedic standpoint, frequent diarrhoeal episodes observed in Pittodara may be interpreted as the body's intrinsic attempt to eliminate accumulated Ama and aggravated Pitta Dosha from the Mahasrotas.  [3]

Pittodara Symptom - เคคเคธ्เคฏ เคฐूเคชाเคฃि- เคฆाเคนเคœ्เคตเคฐเคคृเคท्เคฃाเคฎूเคฐ्เคš्เค›ाเคคीเคธाเคฐเคญ्เคฐเคฎाः [Cha.Chi.13/22] [3]

This slok represents a chronological pathological cascade, tracking the disease from localized gut inflammation to systemic neurological collapse. [3]


       Thus, Pittodara should not be regarded merely as a localized colonic disorder but rather as a chronic systemic disease arising from persistent Agnimandya, Ama formation, Pitta Prakopa, Srotodushti, impaired Dhatu Poshana, and eventual localization of pathology within the Purishavaha Srotas. This comprehensive understanding forms the basis for a Samprapti Vighatana-oriented therapeutic approach, emphasizing Ama Pachana, Agni Deepana, Pitta-Rakta Shamana, Srotoshodhana, Vrana Ropana, Brimhana, and restoration of Ojas and Vyadhikshamatva to achieve sustained mucosal healing and long-term remission. [3]

The Samprapti of Pittodara can be summarized as:

Pitta Prakopaka Nidana Sevana → Pitta Prakopa with Agni Dushti → Chronic dominant Amla Avastha Paka → Formation of Sama Pitta and Sama Rasa Dhatu → Srotodushti and impaired Dhatu Poshana → Progressive Dhatu Kshaya → Picchila Drava Mala Pravritti, Udara Gauravata, Daurbalya, Karshya → Pittodara (Ulcerative Pancolitis). [3]

This Samprapti demonstrates that chronic aggravation of Pitta and persistent Amla Avastha Paka initiate a cascade of Agni Dushti, Ama formation, Srotodushti, and progressive Dhatu Kshaya, ultimately resulting in severe mucosal injury of the Purishavaha Srotas. Therefore, successful management depends on Samprapti Vighatana through Deepana, Ama Pachana, Pitta Shamana, Stambhana, Vrana Ropana, and Brimhana, thereby restoring Agni, promoting mucosal healing, and achieving sustained clinical remission. [3]

Before: 29/08/25



 

DIAGNOSIS

Based on:

  • Clinical presentation
  • Colonoscopy Findings
  • Ayurvedic Lakshanas

Diagnosed as Pittodara(correlated with Ulcerative Colitis)

 

THERAPEUTIC INTERVENTION


1. Shamana Chikitsa

  • Kutaj Ghanvati Dose 2/2/2/2
  • Sansamani Vati 4/4/4/4
  • Sudarshan Ghanavati 2/2/2/2
  • Dadimadi Ghrita 20 ml empty stomach early morning

 

2. Panchakarma

Kshira Basti was selected as the principal Panchakarma intervention owing to its ability to interrupt the Samprapti of Pittodara at multiple levels. Since Vata Dosha, particularly Apana Vayu, plays a pivotal role in the progression and chronicity of Udara Roga, Basti is regarded as the most effective therapeutic modality for restoring its physiological function. [7]

Composition of Kshira Basti

  • Tikta Skandha Kwatha – 100 gms
  • Kshira – 200 ml
  • Jala – 800 ml (reduced to 200 ml during preparation) method: ksheerpak
  • Madhu – 20 ml
  • Ghrita – 20 ml
  • Temp. – Room Temp.

Total Volume: 240 ml

The treatment protocol was structured with targeted Shaman Chikitsa administered continuously for 2 months, supplemented by Tikta skandha kshir basti for 40 days. [7]

Mechanism of Action

  • Regulation of Apana Vayu: As the foremost therapy for Vata, Tikta Skandha Kshira Basti restores the normal function of Apana Vayu, thereby reducing bowel frequency, urgency, and abnormal intestinal motility.  [6,7]
  • Direct Action on the Pakvashaya: Administered through the rectal route, Basti prepared with pittashamak drugs directly reaches the Pakvashaya—the principal seat of Vata and the site of pathology in Pittodara. This enables targeted Samprapti Vighatana at the disease site with ‘raso-nipate dravyanam’ principle. [5,6]
  • Removal of Srotorodha: The Tikta Skandha drugs possess Pitta-Shamaka, Rakta Prasadana, Shothahara, and Vrana Ropana properties, facilitating Srotoshodhana, reducing inflammation, and promoting healing of the ulcerated colonic mucosa.  [3,7]
  • Pacification of Pitta and Vata: The combination of Tikta Dravyas with Kshira and Ghrita provides a balanced therapeutic effect. While Tikta drugs alleviate Pitta and inflammatory pathology, Kshira and Ghrita nourish tissues, pacify Vata, and prevent excessive dryness.  [3,7]
  • Promotion of Vrana Ropana and Dhatu Poshana: Kshira and Ghrita exert mucoprotective [ Brimhana, Jeevaniya, and Rasayana ] effects, supporting regeneration of the damaged intestinal mucosa, improving tissue nutrition, and correcting Dhatu Kshaya.  [3]
  • Restoration of Gastrointestinal Homeostasis: By simultaneously correcting Agni, reducing Ama, pacifying Doshas, and restoring Purishavaha Srotas integrity, Kshira Basti promotes sustained mucosal healing and minimizes disease recurrence.  [3,5,6]

Thus, Kshira Basti acts not merely as a symptomatic therapy but as a comprehensive Samprapti Vighataka intervention, addressing the fundamental pathological mechanisms of Pittodara and facilitating long-term clinical remission. [5,6,7]

Assessment of Disease Improvement:

TABLE 2. SUBJECTIVE PARAMETERS BEFORE TREATMENT

Symptoms

Before treatment

Picchila Drava Mala Pravritti

++++

Udara Gauravata & adhman

++++

Daurbalyata

+++

Sharira Bhara Hani

+++

Jaliya Nasa Srava

++

 

 

TABLE 3. WEEK-WISE IMPROVEMENT IN SUBJECTIVE PARAMETERS

Symptoms

After treatment

1st week

2nd week

3rd week

4th week

Picchila Drava Mala Pravritti

+++

++

+

-

Udara Gauravata & adhman

+++

+

+

-

Daurbalyata

+++

++

+

-

Sharira Bhara Hani

+++

++

+

-

Jaliya Nasa Srava

++

+

-

-

 

Results:

Following the completion of the Ayurvedic treatment protocol for 40 days , patient demonstrated marked clinical, nutritional, and endoscopic improvement, indicating successful Samprapti Vighatana and sustained disease remission.

Clinical Outcomes

  • Significant Reduction in Bowel Frequency: The frequency of bowel movements decreased from 20–25 episodes/day to 2–3 times/day, well-controlled bowel movements/day, with complete resolution of urgency and improved bowel control.
  • Restoration of Normal Stool Characteristics: Stool consistency improved from frequent mucoid watery diarrhoea to well-formed stools. Both rectal bleeding (Rakta Srava) and mucous discharge (Picchila Mala) resolved completely, indicating effective mucosal healing.
  • Improvement in Agni and Appetite: Restoration of Jatharagni was reflected by a marked improvement in appetite and digestion, with complete relief from anorexia and improved tolerance to a normal diet.
  • Reversal of Dhatu Kshaya: Progressive weight gain and improvement in physical strength were observed, indicating restoration of Dhatu Poshana and correction of chronic tissue depletion.
  • Resolution of Associated Symptoms: Systemic manifestations, including generalized weakness (Daurbalya), abdominal heaviness (Udara Gauravata), and recurrent watery nasal discharge (Jaliya Nasa Srava), resolved completely, resulting in a substantial improvement in the patient's overall quality of life.

Endoscopic Outcomes

Follow-up colonoscopic evaluation demonstrated remarkable mucosal healing and near-complete endoscopic remission. The extensive inflammatory changes involving the entire colon observed before treatment showed significant regression. The disease improved from severe ulcerative pancolitis (Montreal Classification E3; Endoscopic Mayo Score 3; UCEIS 6–8) with diffuse ulceration, spontaneous bleeding, and extensive mucosal friability to mild residual disease (Endoscopic Mayo Score 1; UCEIS 2). The sigmoid, descending, and transverse colon appeared completely normal, while only minimal superficial, non-friable erosions persisted in the rectum and ascending colon, without evidence of active bleeding or significant inflammatory activity. [1,2]

Overall, the patient achieved clinical remission, nutritional recovery, and substantial endoscopic remission without any treatment-related adverse events or complications, highlighting the effectiveness of the Samprapti-based Ayurvedic management approach in chronic active ulcerative pancolitis.

A.   Objective Criteria :

Colonoscopy (After treatment):- Date: 13.10.2025

Date: 06.04.2026


Patient's Testimonial


Discussion:

The favorable clinical and endoscopic outcomes observed in this case demonstrate the effectiveness of a Samprapti Vighatana-based Ayurvedic approach in the management of Pittodara correlated with chronic active ulcerative pancolitis. Rather than providing symptomatic relief alone, the treatment addressed the fundamental pathological events, including Agni Dushti, Ama formation, Pitta Prakopa, Srotorodha, and progressive Dhatu Kshaya. Restoration of Jatharagni, elimination of Ama, regulation of Apana Vayu, and healing of the ulcerated colonic mucosa collectively resulted in sustained clinical remission and marked endoscopic improvement. [1,2,3]

The therapeutic strategy was designed to achieve multiple objectives simultaneously. It pacified aggravated Pitta and Rakta, thereby reducing mucosal inflammation, burning sensation (Daha), and rectal bleeding (Rakta Srava). Correction of Apana Vayu through Kshira Basti normalized bowel motility, significantly reducing bowel frequency and urgency. Simultaneously, restoration of the protective Shleshma layer preserved the integrity of the colonic mucosal barrier, preventing further ulceration and facilitating tissue regeneration. Correction of Agni through Deepana and Ama Pachana arrested the continuous formation of Amla Avastha Paka, while Brimhana therapy restored Dhatu Poshana, leading to reversal of Mamsa-Meda Dhatu Kshaya, progressive weight gain, and improved physical strength. [3,7]

Each therapeutic intervention contributed uniquely to the overall clinical outcome. Kutajghan Vati provided potent Grahi, Deepana, Pachana, and Pitta-Vata Shamana actions, effectively controlling chronic diarrhea, mucous discharge, and rectal bleeding. Sudarshan Ghanavati, owing to its Tikta Rasa and Pachana properties, pacified aggravated Pitta, improved Jatharagni, facilitated Ama Pachana, and relieved Srotorodha, thereby reducing abdominal heaviness and distension. Sanshamani Vati acted as an effective Pitta-Rakta Shamaka and Rasayana, helping to regulate systemic inflammatory activity, reduce Daha, and improve associated constitutional symptoms. [3]

Oral administration of Dadimadi Ghrita played a crucial role in Vrana Ropana by promoting healing of the ulcerated colonic mucosa. Its Snigdha, Grahi, and Brimhana properties protected the intestinal mucosal barrier, reduced bowel hypermotility, and supported restoration of normal gastrointestinal function. The principal Panchakarma intervention, Tikta Skandha Kshira Basti, directly targeted the Pakvashaya—the principal seat of Vata and the primary site of pathology. The combined action of Tikta Dravyas, Kshira, and Ghrita facilitated Srotoshodhana, pacified both Pitta and Vata, nourished depleted tissues, accelerated Vrana Ropana, and interrupted the pathological cascade at its site of origin. [3]

The remarkable improvement in bowel frequency, complete cessation of rectal bleeding and mucous discharge, restoration of appetite, weight gain, and near-complete endoscopic mucosal healing collectively indicate successful reversal of the underlying Samprapti. These findings suggest that a comprehensive Ayurvedic treatment protocol integrating Deepana, Ama Pachana, Pitta-Rakta Shamana, Stambhana, Vrana Ropana, Brimhana, and Kshira Basti can effectively restore gastrointestinal homeostasis and induce sustained clinical as well as endoscopic remission in chronic active ulcerative pancolitis. [1,2]

Overall, this case reinforces the principle that management directed toward correcting the underlying Samprapti, rather than suppressing isolated symptoms, has the potential to achieve durable mucosal healing and systemic recovery in Pittodara correlated with Ulcerative Colitis. [3]

 

This case demonstrates the successful management of chronic active Ulcerative Pancolitis through a Samprapti Vighatana-based Ayurvedic approach by correlating the disease with the classical concept of Pittodara. The pathological process was understood as a consequence of persistent Pitta Prakopa, Agni Dushti, chronic Amla Avastha Paka, formation of Sama Pitta and Sama Rasa Dhatu, ultimately leading to Srotodushti, Dhatu Kshaya, and localized injury of the Purishavaha Srotas. This comprehensive understanding formed the basis of the therapeutic strategy rather than merely addressing symptomatic manifestations. [1,2,3]

The integrated treatment protocol, comprising Deepana, Ama Pachana, Pitta-Rakta Shamana, Stambhana, Vrana Ropana, Brimhana, and Tikta Skandha Kshira Basti, effectively restored Jatharagni, corrected Apana Vayu, promoted mucosal healing, and re-established normal Dhatu Poshana. Clinically, this was reflected by normalization of bowel frequency, complete cessation of rectal bleeding and mucous discharge, restoration of appetite, progressive weight gain, and resolution of associated systemic symptoms. Furthermore, follow-up colonoscopy demonstrated marked mucosal healing with near-complete endoscopic remission, indicating that the therapeutic response extended beyond symptomatic relief to objective tissue recovery. [3,7]

Conclusion:

The present case highlights the potential of classical Ayurvedic principles to address both the local inflammatory pathology and the underlying systemic metabolic derangements involved in Ulcerative Colitis. By targeting the root Samprapti, Ayurveda may provide a rational, safe, and holistic therapeutic approach capable of achieving sustained clinical and endoscopic remission. [1,2,3]

However, as these observations are based on a single case, larger prospective clinical studies with standardized treatment protocols, objective biomarkers, endoscopic assessment, and long-term follow-up are warranted to further validate the efficacy and reproducibility of this Ayurvedic management strategy in patients with Ulcerative Colitis.

Conflict of Interest Statement :  

None declared.
















----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Above article has been published in 'International Journal of Ayurveda & Pharma Research

Article Link-

https://ijapr.in/index.php/ijapr/article/view/4410 

Please visit above link for full article.

----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------






Presented by

*Dr.  Vaishali Lalwani

B.A.M.S.

MD IInd Yr. Scholar

P. G. Dept. of Kayachikitsa

Govt. Akhandanand Ayu. College,

Bhadra, Ahmedabad, Gujarat, India

Email: vaishalilalwani93137@gmail.com 


**Dr. Shubham Tripathi

B.A.M.S.

MD IInd Yr. Scholar

P. G. Dept. of Kayachikitsa

Govt. Akhandanand Ayu. College,

Bhadra, Ahmedabad, Gujarat, India

Mob.- +91-6260097626



***Guided by 

Prof. Surendra  A. Soni

H.O.D., 

P. G. Dept. of Kayachikitsa

Govt. Akhandanand Ayu. College,

Bhadra, Ahmedabad, Gujarat, India

Email: kayachikitsagau@gmail.com


Dr. Anamika S. Soni

Associate Professor

P. G. Dept. of Kayachikitsa

Govt. Akhandanand Ayu. College,

Bhadra, Ahmedabad, Gujarat, India

Comments

Popular posts from this blog

CLINICAL AYURVEDA PART-15: Case presentation- เคตिเคถเคฆ เค—ुเคฃ - เคธैเคฆ्เคงाเคจ्เคคिเค• เคเคตं เคช्เคฐाเคฏोเค—िเค• เคธ्เคตเคฐूเคช by Vaidyaraja Subhash Sharma

[12/14, 7:09 PM] Vaidyaraj Subhash Sharma: CLINICAL AYURVEDA PART-15 *case presentation-  เคตिเคถเคฆ เค—ुเคฃ - เคธैเคฆ्เคงाเคจ्เคคिเค• เคเคตं เคช्เคฐाเคฏोเค—िเค• เคธ्เคตเคฐूเคช เคฎें ENLARGEMENT OF PROSTATE & PSA เค•े เค‰เคฆाเคนเคฐเคฃ เค•े เคธाเคฅ ....* *เคธเคฐ्เคตเคช्เคฐเคฅเคฎ เคตिเคถเคฆ เค•ी เคจिเคฐूเค•्เคคि เคเคตं เคชเคฐिเคญाเคทा เคฆेเค–ें เคคो เคชृเคฅเคฎ เคฆृเคท्เคŸि เคฎें เคนी เค‡เคธเค•ा เคฎเคนเคค्เคต เคšिเค•िเคค्เคธा เคฎें เค•िเคคเคจा เค…เคงिเค• เคนै เคฏเคน เคธ्เคชเคท्เคŸ เคนो เคœाเคคा เคนै, 'เคถเคคเคฒृ เคถाเคคเคจे' เคงाเคคु เคฎें เคŸเค•् เคช्เคฐเคค्เคฏเคฏ เคธे เคตिเคธเคฐ्เค— เคชूเคฐ्เคตเค• เคตिเคถเคฆ เคถเคฌ्เคฆ เค•ी เค‰เคค्เคชเคค्เคคि เคนोเคคी เคนै เคœिเคธเค•ा เค…เคญिเคช्เคฐाเคฏ เคถुเคฆ्เคง เคฌเคจा เคฆेเคจा เค”เคฐ เคธंเคถोเคงเคจ เค•เคฐ เคฆेเคจा เคนै।* *เคธुเคถ्เคฐुเคค เค•ी เคนेเคฎाเคฆ्เคฐि เคŸीเค•ा เคฎें เค‡เคธे 'เคถुเคšि เคตिเคฎเคฒी เคคु เคตिเคถเคฆ เคตिเคถेเคทौ เค…เคฆृเคท्เคŸाเคจा เคนि เคฎเคฒाเคจां เค•्เคทाเคฒเคจे เคถเค•्เคคिं เคถुเคšिเคค्เคตं เคฆृเคท्เคŸाเคจां เคตिเคฎเคฒเคค्เคต' เคฒिเค–ा เคนै เค…เคฐ्เคฅाเคค เคœो เคฆ्เคฐเคต्เคฏ เคถเคฐीเคฐ เคฎें เคฆोเคท, เคงाเคคु เคเคตं เคฎเคฒों เค•ा เคถुเคฆ्เคงिเค•เคฐเคฃ เค•เคฐ เค•े เค‰เคจ्เคนे เคตिเคฎเคฒเคค्เคต เค…เคฐ्เคฅाเคค เคถुเคฆ्เคง, เคจिเคฐ्เคฎเคฒ เคเคตं เคชाเคฐเคฆเคฐ्เคถी เคธเคฆृเคถ เคฌเคจा เคฆे เค‰เคธे เคตिเคถเคฆ เค•เคนा เค—เคฏा เคนै।* *'เคชिเคš्เค›िเคฒो เคœीเคตเคจो เคฌเคฒ्เคฏः เคธเคจ्เคงाเคจः เคถ्เคฒेเคท्เคฎเคฒो เค—ुเคฐुः, เคตिเคถเคฆो เคตिเคชเคฐीเคคोเคฝเคธ्เคฎाเคค् เค•्เคฒेเคฆाเคšूเคทเคฃเคฐोเคชเคฃः'  เคธु เคธू 46/517  เคฏเคนां เค†เคšाเคฐ्เคฏ เคธुเคถ्เคฐुเคค เค‡เคธे เคชिเคš्เค›िเคฒ เค•े เคตिเคชเคฐीเคค เค•เคฐ्เคฎ เคตाเคฒा เค…เคฐ्เคฅाเคค เคถเคฐीเคฐ เคฎें เคธे เค•्เคฒेเคฆ เค•ा เคถोเคทเคฃ เค•เคฐ เคจिเคฐ्เคฎเคฒ เคฌเคจाเคคा เคนै เค”เคฐ เคฐोเคชเคฃ เค•เคฐ्เคฎ เคญी เค•เคฐเคคा เคนै।เคœो เคถเคฐीเคฐ เคฎें ...

Case presentation: เคฏเค•ृเคฆ्เคฆाเคฒ्เคฏुเคฆเคฐ {Non Alcoholic Fatty Liver Disease (NAFLD)} by Vaidyaraja Subhash Sharma

*Case-presentation*  - เคฏเค•ृเคฆ्เคฆाเคฒ्เคฏुเคฆเคฐ-  Non-Alcoholic Fatty Liver Disease (NAFLD) progressing to Compensated Cirrhosis * -------------------- *Vaidyaraja Subhash Sharma, MD (kaya chikitsa, jamnagar - 1985)* --------------- *Chapter -1* *เคฎाเคงเคต เคจिเคฆाเคจ เค•ा เค•ाเคฒ 1200 เคธे 1400 เคตเคฐ्เคท เคชूเคฐ्เคต เคคเค• เคฎाเคจा เค—เคฏा เคœिเคธเคฎें เค‰เคฆเคฐ เคฐोเค—ों เคฎें เคฏเค•ृเคฆ्เคฆाเคฒ्เคฏुเคฆเคฐ เค•ा เค‰เคฒ्เคฒेเค– เคฒเค•्เคทเคฃों เคธเคนिเคค เคนै। เคคเคฌ เคคो liver fibroscan เค•ी เคธुเคตिเคงा เคจเคนीं เคฅी।เค•िเคธ เคช्เคฐเค•ाเคฐ เคธे เค†เคšाเคฐ्เคฏ เค‡เคธ เคช्เคฐเค•ाเคฐ เค•ी เค—ंเคญीเคฐ เคต्เคฏाเคงिเคฏों เค•ी เคชเคฐीเค•्เคทा เค•เคฐ เคธเคŸीเค• เคจिเคฆाเคจ เคเคตं เคšिเค•िเคค्เคธा เค•เคฐเคคे เคฅे ! เค†เคœ เคธ्เคชเคท्เคŸ เค•เคฐेंเค—े เคšिเค•िเคค्เคธोเคชเคฏोเค—ी เคถाเคธ्เคค्เคฐों เคฎें เค‡เคธ เคฐोเค— เคชเคฐ เคตเคฐ्เคฃिเคค เคธूเคค्เคฐों เค•ी clinical applications...* *1- เคœ्เคžाเคจेเคจ्เคฆ्เคฐिเคฏों เคเคตं เค•เคฐ्เคฎेเคจ्เคฆ्เคฐिเคฏों เค•ो เคธเคฎเคฐ्เคฅ เคเคตं เคธเค•्เคทเคฎ เคฌเคจाเค•เคฐ เคจिเคฆाเคจ เคฎें เค‰เคชเคฏोเค—।* *2- เคฏเค•ृเคฆ्เคฆाเคฒ्เคฏुเคฆเคฐ เค•ी เคค्เคฐिเคตिเคง เคชเคฐीเค•्เคทा* *3- a- เคฆเคถเคตिเคง เคชเคฐीเค•्เคทा*      *b- เคค्เคฐिเคตिเคง เคช्เคฐเคฎाเคฃ เค”เคฐ เคฏुเค•्เคคि* *4- เคœैเคธे เคธเคญी เคฆ्เคฐเคต्เคฏ เคชंเคšเคญौเคคिเค• เคนैं เคคो เคฐोเค— เคญी เคชंเคšเคญौเคคिเค• เคนै, เค‡เคธเค•ी เคชंเคšเคญौเคคिเค•เคคा।* *5- เคฐोเค—ी เค•े เคจा เคฌเคคाเคจे เคชเคฐ เคญी เคšिเคจ्เคนों เคฆ्เคตाเคฐा เค‡เคธเค•ा เคฏा เค…เคจ्เคฏ เคฐोเค—ों เค•ा เคญी เคจिเคฐ्เคฃเคฏ เค•เคฐเคจा।* *6- เคฏเค•ृเคฆ्เคฆाเคฒ्เคฏुเคฆเคฐ เค•े เคฆोเคท-เคฆूเคท्เคฏ-เคธ्เคฐोเคคเคธ-เคธ्เคฐोเคคोเคฆुเคท्เคŸि-เค…เค—्...

'CLINICAL AYURVEDA' Part-1 by Vaidyaraja Subhash Sharma

[11/23/2020, 1:49 PM] Vaidyaraj Subhash Sharma Sir Delhi:  *เค•्เคฒिเคจिเค•เคฒ เค†เคฏुเคฐ्เคตेเคฆ - เคญाเค— 1 * *เค•ाเคฏ เคธเคฎ्เคช्เคฐเคฆाเคฏ เค•े เคฒिเคฏे เคถाเคธ्เคค्เคฐोเค•्เคค เคœ्เคžाเคจ เค•ो clinical practice เคฎें เคนเคฎ เค•ैเคธे apply เค•เคฐเคคे เคนैं เค”เคฐ เคฐोเค—ी เคฐोเค— เคฎुเค•्เคค เคนोเคคा เคœाเคคा เคนै, เคเค• เคชूเคฐी series เค•े เคฐूเคช เคฎें เคฒिเค–เคจे เค•ा เคช्เคฐเคฏाเคธ เค•िเคฏा เคนै, เค•ुเค› เคตिเคทเคฏ เค•เค िเคจ เคฒเค—ेเค—ें เค•्เคฏोंเค•ि เคฏเคน post graduation เคฏा Ph.D เคตिเคทเคฏ เค•ा เคœ्เคžाเคจ เคนै เคœिเคธे เคนเคฎ เคธเคฐเคฒ เค•เคฐ เค•े เคšเคฒेंเค—े เคœिเคธ เคธे เคธाเคฎाเคจ्เคฏ เค†เคฏुเคฐ्เคตेเคฆ graduates เคญी เคฒाเคญाเคจ्เคตिเคค เคนोंเค—े -   เคตैเคฆ्เคฏเคฐाเคœ เคธुเคญाเคท เคถเคฐ्เคฎा, เคเคฎ.เคกी.(เค•ाเคฏ เคšिเค•िเคค्เคธा -เคœाเคฎเคจเค—เคฐ 1985), เค†เคœ เคชเคนเคฒी เคญाเค— เค†เคชเค•े เคธाเคฎเคจे เคนै।* *เคจीเคšे เคฆिเคฏे เค—เคฏे เคตीเคกिเคฏो เค•ो เคฌเคนुเคค เคง्เคฏाเคจ เคธे เคฆेเค–िเคฏे, zoom เค•เคฐ เค•े เคญी เคฆेเค–े, เคฐोเค—ी เค•ा เคฎुเค–, เคชाเคฆ, เคนเคธ्เคค เค”เคฐ เคšเคฒเคจे เคธे เคชเคนเคฒे เค•ा เคช्เคฐเคฏाเคธ เค”เคฐ เคซिเคฐ เค•िเคธ เคช्เคฐเค•ाเคฐ เคธे เค‰เคธเคจे เค—เคคि เคชเค•เคก़ी ...*  [11/23/2020, 1:49 PM] Vaidyaraj Subhash Sharma Sir Delhi:  *เคฒเค—เคญเค— เคฆो เคฎเคนीเคจे เค•े เคฌाเคฆ เค‡เคธ เคฐोเค—ी เค•ा เคฒिเคฏा เค—เคฏा เคฆूเคธเคฐा เคตीเคกिเคฏो เคฆेเค–िเคฏे, เคฐोเค— เคคो เค…เคธाเคง्เคฏ เคนै เคœो เคฐोเค—ी เค•ो เคชเคนเคฒे เคนी เคฌเคคा เคฆिเคฏा เค—เคฏा เคฅा เคชเคฐ เคธเคฎ्เคช्เคฐाเคช्เคคि เคตिเค˜เคŸเคจ เคธे เคฐोเค—ी เคฎें เค†เคค्เคฎเคตिเคถ्เคตाเคธ เค”เคฐ เคฎเคจोเคฌเคฒ เค•ी เคคो เคตृเคฆ्เคงि เคนुเคˆ เคนी เคธाเคฅ เคฎें เคฐोเค—ी เค…เคชเคจे เคฆोเคจो เคชांเคต เค‰เค ाเค•เคฐ เคธเคฐเคฒเคคा เคธे เคšเคฒ เคฒेเคคा เคนै।* [11/23/2020, 1:49...